We are live on
!
Find out more
Capital Analysts LLC Portfolio holdings
AUM
$4.34B
Turnover
9.37%
1-Year Est. Return
17.55%
This Fund
S&P 500
This Quarter
Est. Return
+4.26%
1 Year Est. Return
+17.55%
3 Year Est. Return
+51.26%
5 Year Est. Return
+53.67%
10 Year Est. Return
+179.02%
AUM
$1.8B
AUM Growth
+$51.4M
(+2.9%)
Cap. Flow
-$10.7M
Cap. Flow
% of AUM
-0.59%
Top 10 Holdings %
Top 10 Hldgs %
35.69%
Holding
1,038
New
72
Increased
361
Reduced
285
Closed
42
Avg Time Held
3.6
years
Top 10 Avg Time Held
2.5
years
Top 20 Avg Time Held
2.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$25.1M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$16.1M |
| 3 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$5.63M |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
+$5.12M |
| 5 |
CVS Health
CVS
|
+$3.36M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Northern Trust Morningstar Global Upstream Natural Resources ETF
GUNR
|
+$24M |
| 2 |
State Street SPDR S&P Dividend ETF
SDY
|
+$15M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$11M |
| 4 |
iShares S&P 500 Value ETF
IVE
|
+$6.95M |
| 5 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$6.88M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 68.62% |
| 2 | Technology | 7.64% |
| 3 | Healthcare | 4.73% |
| 4 | Financials | 4.51% |
| 5 | Industrials | 3.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
ConocoPhillips
COP
$176B
| $11.5M | 0.64% |
111,222
+3,417
| +3% | +$351K |
2018 Q1
21 quarters
|
|
27
Procter & Gamble
PG
$370B
| $11.2M | 0.62% |
73,940
+3,268
| +5% | +$493K |
2013 Q2
40 quarters
|
|
28
Goldman Sachs
GS
$257B
| $10.7M | 0.59% |
33,125
+1,228
| +4% | +$404K |
2013 Q2
40 quarters
|
|
29
RTX Corp
RTX
$261B
| $10.7M | 0.59% |
108,828
+3,801
| +4% | +$372K |
2013 Q2
40 quarters
|
|
30
iShares S&P 500 Growth ETF
IVW
$76.7B
| $10.4M | 0.58% |
146,978
-47,793
| -25% | -$3.16M |
2013 Q2
40 quarters
|
|
31
WisdomTree Emerging Markets High Dividend Fund
DEM
$4.11B
| $10M | 0.56% |
262,351
-5,488
| -2% | -$211K |
2022 Q1
5 quarters
|
|
32
Visa
V
$756B
| $9.8M | 0.54% |
41,253
+1,779
| +5% | +$407K |
2013 Q2
40 quarters
|
|
33
Vanguard High Dividend Yield ETF
VYM
$81.6B
| $9.75M | 0.54% |
94,102
-1,471
| -2% | -$154K |
2013 Q2
40 quarters
|
|
34
Motorola Solutions
MSI
$76.6B
| $9.67M | 0.54% |
32,984
+1,100
| +3% | +$315K |
2019 Q4
14 quarters
|
|
35
DELISTED
iShares Frontier and Select EM ETF
FM
| $9.42M | 0.52% |
364,105
+3,754
| +1% | +$95.4K |
2017 Q1
25 quarters
|
|
36
JPMorgan Equity Premium Income ETF
JEPI
$45.8B
| $9.23M | 0.51% |
166,807
+2,877
| +2% | +$157K |
2021 Q1
9 quarters
|
|
37
Vanguard Morningstar Growth ETF
VUG
$227B
| $8.65M | 0.48% |
183,504
-1,428
| -0.8% | -$61.9K |
2018 Q1
21 quarters
|
|
38
Elevance Health
ELV
$92.9B
| $8.55M | 0.48% |
19,245
+851
| +5% | +$393K |
2017 Q2
24 quarters
|
|
39
Air Products & Chemicals
APD
$66.7B
| $8.48M | 0.47% |
28,327
+1,499
| +6% | +$427K |
2017 Q2
24 quarters
|
|
40
JPMorgan Core Plus Bond ETF
JCPB
$15.8B
| $8.42M | 0.47% |
180,780
+6,099
| +3% | +$287K |
2020 Q1
13 quarters
|
|
41
Morgan Stanley
MS
$284B
| $8.34M | 0.46% |
97,639
+4,831
| +5% | +$413K |
2017 Q3
23 quarters
|
|
42
Zoetis
ZTS
$32.8B
| $8.19M | 0.45% |
47,564
+2,301
| +5% | +$398K |
2019 Q1
17 quarters
|
|
43
iShares US Medical Devices ETF
IHI
$3.73B
| $7.9M | 0.44% |
142,088
-2,373
| -2% | -$131K |
2021 Q1
9 quarters
|
|
44
Becton Dickinson
BDX
$52.2B
| $7.89M | 0.44% |
29,875
+1,772
| +6% | +$450K |
2017 Q2
24 quarters
|
|
45
Vanguard Dividend Appreciation ETF
VIG
$113B
| $7.83M | 0.44% |
49,194
-443
| -0.9% | -$69.4K |
2016 Q3
27 quarters
|
|
46
Comcast
CMCSA
$77.7B
| $7.82M | 0.43% |
188,251
+14,570
| +8% | +$579K |
2013 Q2
40 quarters
|
|
47
Bunge Global
BG
$20.4B
| $7.79M | 0.43% |
82,575
+4,868
| +6% | +$452K |
2022 Q4
2 quarters
|
|
48
Citigroup
C
$208B
| $7.74M | 0.43% |
168,207
+17,105
| +11% | +$801K |
2017 Q1
25 quarters
|
|
49
JPMorgan Chase
JPM
$902B
| $7.73M | 0.43% |
53,137
+13,165
| +33% | +$1.81M |
2013 Q2
40 quarters
|
|
50
Berkshire Hathaway Class B
BRK.B
$1.14T
| $7.72M | 0.43% |
22,936
+1,694
| +8% | +$553K |
2017 Q2
24 quarters
|
|
Similar funds
ZP
AIIMS
Capital Analysts LLC's Q2 2023 Portfolio in Review
As of Q2 2023, Capital Analysts LLC held 1,038 positions worth $1.8B, up 2.9% from $1.75B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Capital Analysts LLC's Q2 2023 filing shows 72 new, 361 increased, 285 reduced and 42 closed positions. Its largest new stake was Innovator US Equity Power Buffer ETF July: 32,021 shares worth $1.1M. The largest sale was Northern Trust Morningstar Global Upstream Natural Resources ETF, an estimated $24M.
By sector, the portfolio is most concentrated in Miscellaneous at 69% of assets, down from 69% a quarter earlier, followed by Technology and Healthcare.
- Capital Analysts LLC's largest Q2 2023 buy was Innovator US Equity Power Buffer ETF July: 32,021 shares worth $1.1M.
- Capital Analysts LLC added most to State Street SPDR Portfolio S&P 500 ETF in Q2 2023, an estimated $25.1M increase.
- Capital Analysts LLC's biggest Q2 2023 reduction was Northern Trust Morningstar Global Upstream Natural Resources ETF, cutting an estimated $24M.
- Capital Analysts LLC fully exited iShares US Telecommunications ETF in Q2 2023, selling an estimated $154K.
- Capital Analysts LLC's ten largest holdings make up 36% of its $1.8B portfolio in Q2 2023.
- Capital Analysts LLC opened 72 new positions and closed 42 in Q2 2023.
- Capital Analysts LLC's portfolio value rose 2.9% quarter-over-quarter to $1.8B.
Based on Capital Analysts LLC's 13F filing for Q2 2023, filed 11 Aug 2023.